Adrienne Farid's Insider Trades & SAST Disclosures
Adrienne Farid's most recent trade in Century Therapeutics Inc was a trade of 120,000 Common Stock done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Adrienne Farid.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 251,717 | - | 0 | Common Stock | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 2,359 | 131,717 | - | 0.6 | 1,451 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 1,054 | 134,076 | - | 0.8 | 822 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 04 Nov 2024 | 1,033 | 135,130 | - | 1.2 | 1,267 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 05 Aug 2024 | 1,073 | 136,163 | - | 1.8 | 1,960 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 03 May 2024 | 913 | 137,236 | - | 3.1 | 2,836 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 24,000 | 138,149 | - | 0 | Common Stock | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 06 Mar 2024 | 30,684 | 144,833 | - | 1.0 | 31,605 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 06 Mar 2024 | 30,684 | 114,149 | - | 5.0 | 152,340 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 30,684 | 191,486 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 06 Mar 2024 | 22,831 | 136,980 | - | 1.0 | 23,516 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 5.14 per share. | 06 Mar 2024 | 22,831 | 114,149 | - | 5.1 | 117,342 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 22,831 | 168,655 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Farid Adrienne | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 485 | 222,170 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 16 Feb 2024 | 485 | 114,634 | - | 1.0 | 500 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 16 Feb 2024 | 485 | 114,149 | - | 4.9 | 2,358 | Common Stock |
|
Century Therapeutics Inc
|
Farid Adrienne | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 05 Feb 2024 | 2,035 | 115,933 | - | 3.8 | 7,816 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.49 per share. | 05 Feb 2024 | 1,784 | 114,149 | - | 4.5 | 8,005 | Common Stock |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 96,093 | - | 0 | Common Stock | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 117,968 | - | 0 | Common Stock | |
|
Century Therapeutics Inc
|
Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges